Analyst Ratings for Zimmer Biomet (ZBH)
ZBH Rating Summary
ZBH Price Target Summary
- Highest: $160.00 (JMP Securities)
- Lowest: $109.00 (UBS)
- Average: $137.05
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$137.05 (+14.4%)
* Over Last 12-Mos
Rating Score: 4.6 / 10
Percentile Rank: 47%
Avg. $ Target:
$137.05 (+14.4%)
* Over Last 12-Mos
Rating Score: 4.6 / 10
Percentile Rank: 47%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/4/2024 | Evercore ISI | Vijay Kumar | Downgrade | In Line (Outperform) |
125.00 (135.00) |
120.47 (119.75) |
-0.6% | Details |
| 12/14/2023 | Nephron | Chris Pasquale | Upgrade | Buy (Hold) |
145.00 (N/A) |
117.90 (119.75) |
1.57% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
